Nicotinell Mintfrisch Zur Raucherentwöhnung (Nicotine Polacrilex)

Nicotine polacrilex is a resin‑bound form of nicotine that releases the active compound slowly when placed in the mouth. The nicotine is absorbed through the buccal lining, stimulating nicotinic acetylcholine receptors in the brain. This mimics the effect of cigarette‑derived nicotine, reducing the intensity of withdrawal and helping the user transition away from smoking.

The specific dosing regimen for Nicotinell Mintfrisch is determined by the prescribing healthcare professional based on the individual’s smoking history, level of dependence, and overall health. Patients should follow the prescriber’s instructions and the product’s labeling for the appropriate frequency and duration of use.

Safety data for nicotine polacrilex in pregnancy and lactation are limited. Healthcare providers generally advise caution, as nicotine can cross the placenta and be present in breast milk. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss the risks and benefits with their physician before using this product.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the sales team provides pricing, availability, shipping details, and any necessary import documentation.

Nicotinell Mintfrisch delivers nicotine via a buccal system, similar to nicotine gum or lozenges, but uses nicotine polacrilex for a slower, more controlled release. Compared with nicotine patches, it offers flexible dosing and rapid onset, while providing a discreet, chew‑type format that some users find more convenient than inhalers or sprays.

Store the product at ambient temperature, preferably below 25 °C. Keep it in the original packaging to protect it from moisture and direct sunlight. Do not refrigerate or freeze the product, as extreme temperatures may affect the integrity of the nicotine polacrilex matrix.

The product is placed in the mouth and allowed to dissolve slowly against the buccal mucosa. Users should avoid chewing or swallowing the tablet/lozenge until the nicotine is fully released, and should not eat or drink for several minutes after placement to ensure optimal absorption.

Serious risks, though rare, include cardiovascular events such as increased heart rate, elevated blood pressure, or angina, especially in individuals with pre‑existing heart disease. Allergic reactions presenting as rash, swelling, or breathing difficulty also require immediate medical attention.

Individuals with known hypersensitivity to nicotine or any excipients in the product should avoid use. It is also contraindicated for people who have experienced a recent myocardial infarction, severe uncontrolled hypertension, or who are using other nicotine‑containing products without medical guidance.